# reload+after+2024-01-20 11:46:15.738656
address1§2701 Kent Avenue
city§West Lafayette
state§IN
zip§47906
country§United States
phone§765 463 4527
website§https://www.inotivco.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services, including computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes general and genetic toxicology, regulated bioanalysis, carcinogenicity studies, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services, as well as model and research services. The company operates in the United States, the Netherlands, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
fullTimeEmployees§1955
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Robert W. Leasure Jr.', 'age': 63, 'title': 'President, CEO & Director', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 1692496, 'exercisedValue': 0, 'unexercisedValue': 1227580}, {'maxAge': 1, 'name': 'Ms. Beth A. Taylor CPA', 'age': 58, 'title': 'Senior VP of Finance & CFO', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 457575, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Adrian  Hardy Ph.D.', 'age': 52, 'title': 'Executive VP of Global Marketing & Corporate Development', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 2741606, 'exercisedValue': 0, 'unexercisedValue': 2461998}, {'maxAge': 1, 'name': 'Dr. John E. Sagartz D.V.M., DiplomateACVP, Ph.D.', 'age': 57, 'title': 'Chief Strategy Officer & Director', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 443853, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Peter T. Kissinger', 'age': 78, 'title': 'Founder, Chairman Emeritus & Scientific Advisor', 'yearBorn': 1945, 'fiscalYear': 2022, 'totalPay': 330118, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John Gregory Beattie DSA', 'age': 57, 'title': 'Chief Operating Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brennan  Freeman', 'age': 36, 'title': 'VP of Finance, Principal Accounting Officer & Corporate Controller', 'yearBorn': 1987, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Andrea  Castetter', 'title': 'Senior VP, General Counsel & Corporate Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeffrey Arthur Krupp', 'age': 52, 'title': 'Chief Human Resources Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael  Garrett M.S.', 'age': 56, 'title': 'Chief Commercial Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§8
compensationRisk§8
shareHolderRightsRisk§9
overallRisk§10
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§2.813
priceToSalesTrailing12Months§0.19058406
currency§USD
dateShortInterest§1702598400
forwardEps§-1.09
exchange§NCM
quoteType§EQUITY
shortName§Inotiv, Inc.
longName§Inotiv, Inc.
firstTradeDateEpochUtc§880468200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§18318147-29bb-3d77-9298-f38cbec7e217
gmtOffSetMilliseconds§-18000000
targetHighPrice§25.0
targetLowPrice§3.0
targetMeanPrice§12.67
targetMedianPrice§10.0
recommendationMean§2.3
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§0.943
grossMargins§0.28902
ebitdaMargins§0.079450004
trailingPegRatio§None
